RHYTHM PHARMACEUTICALS, INC.

Develops precision medicines for rare genetic diseases causing severe obesity and hyperphagia.

RYTM | US

Overview

Corporate Details

ISIN(s):: US76243J1051
LEI:
Country:: United States of America
Address:: 222 BERKELEY STREET, 2116 BOSTON
Website:: https://rhythmtx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rhythm Pharmaceuticals, Inc. is a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing precision medicines for rare neuroendocrine diseases. The company focuses on treating conditions characterized by hyperphagia (insatiable hunger) and severe obesity that stem from rare genetic deficiencies. Its lead therapeutic, setmelanotide (marketed as IMCIVREE), is a precision medicine designed to address the root cause of these disorders by targeting the melanocortin-4 receptor (MC4R) pathway. Rhythm is advancing a portfolio of treatment options to transform the lives of patients and families affected by these debilitating conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:05	Regulatory News Service 8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)	English	126.1 KB

Automate Your Workflow. Get a real-time feed of all RHYTHM PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RHYTHM PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RHYTHM PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AVADEL PHARMACEUTICALS PLC Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.	United States of America	AVDL
Avidity Biosciences, Inc. Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.	United States of America	RNA
Axsome Therapeutics, Inc. Biopharma company developing novel therapies for central nervous system (CNS) conditions.	United States of America	AXSM
AYTU BIOPHARMA, INC Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.	United States of America	AYTU
Azitra, Inc. Developing engineered proteins and live biotherapeutics for rare skin diseases.	United States of America	AZTR
Bachem Holding AG A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.	Switzerland	BANB
Barinthus Biotherapeutics plc. Develops T cell immunotherapies for autoimmune and chronic infectious diseases.	United States of America	BRNS
Basilea Pharmaceutica AG Develops & commercializes anti-infectives for severe bacterial & fungal infections.	Switzerland	BSLN
Bausch Health Companies Inc. Develops, manufactures, and markets pharmaceuticals, OTCs, and medical devices globally.	United States of America	BHC
Bavarian Nordic A biotech firm developing and manufacturing life-saving vaccines for travel and public health.	Denmark	BAVA